Inventor
LIM JEE WOONG
KR19 patents
⚠️ This page may combine multiple inventors who share the name “LIM JEE WOONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CJ CORP
8 patentsUS7019144B2Mar 28, 2006
1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
CJ CORP11 citations82
US7288652B2Oct 30, 2007
Method for preparing oltipraz
CJ CORP8 citations72
US6777434B2Aug 17, 2004
Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
CJ CORP2 citations62
US7169929B2Jan 30, 2007
Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
CJ CORP2 citations61
US7135572B2Nov 14, 2006
Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
CJ CORP4 citations61
US6727268B2Apr 27, 2004
2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
CJ CORP2 citations61
US6946558B2Sep 20, 2005
Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
CJ CORP0 citations51
US6689805B2Feb 10, 2004
Pyrazole-3-one derivative, method for preparing the same, and pharmaceutical composition containing the same
CJ CORP1 citations51
CHEIL JEDANG CORP
4 patentsUS6599929B2Jul 29, 2003
1H-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
CHEIL JEDANG CORP75 citations96
US6583321B1Jun 24, 2003
4′-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
CHEIL JEDANG CORP8 citations72
US6686493B2Feb 3, 2004
3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
CHEIL JEDANG CORP0 citations51
US6768019B2Jul 27, 2004
3,4-dihydro-1H-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor
CHEIL JEDANG CORP0 citations50
J2H BIOTECH INC
3 patentsUS11485716B2Nov 1, 2022
Compounds useful for treatment or prevention of muscular dystrophy and derivatives for treatment, amelioration or prevention of muscular dystrophy in medicinal use thereof
J2H BIOTECH INC1 citations57
US12011443B2Jun 18, 2024
Pharmaceutical composition for preventing or treating nonalcoholic steatohepatitis
J2H BIOTECH INC0 citations53
US11427547B2Aug 30, 2022
Edaravone prodrug compound and pharmaceutical use thereof in treatment or alleviation of neurodegenerative or motor neuron disease
J2H BIOTECH INC0 citations53